Activation of poly(ADP-ribose) polymerase-1 delays wound healing by regulating keratinocyte migration and production of inflammatory mediators

Molecular Medicine

Volumn 20, Issue JULY-DECEMBER 2014, 2014, Pages 363-371

  El Hamoly, Tarek ^a,b,c   Hegedűs, Csaba ^a   Lakatos, Petra ^a   Kovács, Katalin ^a,d   Bai, Péter ^a,e   El Ghazaly, Mona A ^b   El Denshary, Ezzeddin S ^c   Szabó, Éva ^a   Virág, László ^a,d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b HOT LABORATORIES CENTER   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d MTA de Cell Biology and Signaling Research Group   (Hungary)

^e MTA DE Lendulet Laboratory of Cellular Metabolism   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINOBENZAMIDE; 3 NITROTYROSINE; AUTACOID; CYCLOOXYGENASE 2; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE 17; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRIC OXIDE SYNTHASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, MOUSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN-6, MOUSE; MESSENGER RNA; MMP9 PROTEIN, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOS2 PROTEIN, MOUSE; PARP1 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; TIMP1 PROTEIN, MOUSE;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLAMMATION; KERATINOCYTE; KERATINOCYTE MIGRATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; OXIDATIVE STRESS; PARP 1 GENE; PHENOTYPE; PROTEIN EXPRESSION; SCRATCH ASSAY; SKIN INJURY; WILD TYPE; WOUND HEALING IMPAIRMENT; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; GENETICS; METABOLISM; PHYSIOLOGY; SKIN; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CYCLOOXYGENASE 2; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 9; MICE, INBRED BALB C; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; RNA, MESSENGER; SKIN; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 84921911496     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2014.00130     Document Type: Article

References (41)

1. Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. (2012) Reactive oxygen species (ROS)—a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur. Cell. Mater. 24:249–65.
2. Staylor A. (2009) Wound care devices: growth amid uncertainty. MedTech Insight. 11:32–47.
3. Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes. 2010 O.J. L 276/33.
4. de Murcia JM, et al. (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. U. S. A. 94:7303–7.
5. Muller-Decker K, Hirschner W, Marks F, Furstenberger G. (2002) The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin. J. Invest. Dermatol. 119:1189–95.
6. Sullivan SR, et al. (2007) Topical application of laminin-332 to diabetic mouse wounds. J. Dermatol. Sci. 48:177–88.
7. Lim Y, Levy M, Bray TM. (2004) Dietary zinc alters early inflammatory responses during cutaneous wound healing in weanling CD-1 mice. J. Nutr. 134:811–6.
8. Munoz-Gamez JA, et al. (2009) PARP-1 is involved in autophagy induced by DNA damage. Autophagy. 5:61–74.
9. Szabo E, et al. (2001) Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone- induced contact hypersensitivity. J. Invest. Dermatol. 117:74–80.
10. Kioka N et al. (2010) Crucial role of vinexin for keratinocyte migration in vitro and epidermal wound healing in vivo. Exp. Cell Res. 316:1728–38.
11. Gill SE, Parks WC. (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 40:1334–47.
12. Virag L, Szabo C. (2002) The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54:375–429.
13. Virag L, Robaszkiewicz A, Rodriguez-Vargas JM, Oliver FJ. (2013) Poly(ADP-ribose) signaling in cell death. Mol. Aspects Med. 34:1153–67.
14. Szabo C, et al. (1998) Protection against peroxynitrite- induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc. Natl. Acad. Sci. U. S. A. 95:3867–72.
15. Scott GS, Hake P, Kean RB, Virag L, Szabo C, Hooper DC. (2001) Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 117:78–86.
16. Virag L, et al. (2002) Nitric oxide-peroxynitritepoly(ADP-ribose) polymerase pathway in the skin. Exp. Dermatol. 11:189–202.
17. Mirza RE, Fang MM, Weinheimer-Haus EM, Ennis WJ, Koh TJ. (2014) Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. 63:1103–14.
18. Falanga V, et al. (2007) Autologous bone marrowderived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 13:1299–312.
19. Chen JS, Wong VW, Gurtner GC. (2012) Therapeutic potential of bone marrow-derived mesenchymal stem cells for cutaneous wound healing. Front. Immunol. 3:192.
20. Singer NG, Caplan AI. (2011) Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6:457–78.
21. Zgheib C. (2014) Fetal skin wound healing is characterized by a reduced inflammatory response. Adv. Wound Care (New Rochelle). 3:344–55.
22. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N. (2002) Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16:963–74.
23. Streit M, Beleznay Z, Braathen LR. (2006) Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int. Wound J. 3:171–9.
24. Thomay AA, et al. (2009) Disruption of interleukin-1 signaling improves the quality of wound healing. Am. J. Pathol. 174:2129–36.
25. Gallucci RM, et al. (2001) Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J. Interferon Cytokine Res. 21:603–9.
26. Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N. (2003) Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J. Leukoc. Biol. 73:713–21.
27. Yamasaki K, et al. (1998) Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J. Clin. Invest. 101:967–71.
28. Most D, Efron DT, Shi HP, Tantry US, Barbul A. (2002) Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice. Surgery. 132:866–76.
29. Park JE, Abrams MJ, Efron PA, Barbul A. (2013) Excessive nitric oxide impairs wound collagen accumulation. J. Surg. Res. 183:487–92.
30. Avlan D, Unlu A, Ayaz L, Camdeviren H, Nayci A, Aksoyek S. (2005) Poly (ADP-ribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury. Pediatr. Surg. Int. 21:449–55.
31. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. (2001) The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276:45588–97.
32. Kauppinen TM, Swanson RA. (2005) Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase- 9-mediated neuron death. J. Immunol. 174:2288–96.
33. Liu Y, et al. (2009) Increased matrix metalloproteinase- 9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 32:117–9.
34. Simbulan-Rosenthal CM, et al. (1996) The expression of poly(ADP-ribose) polymerase during differentiation- linked DNA replication reveals that it is a component of the multiprotein DNA replication complex. Biochemistry. 35:11622–33.
35. Eki T. (1994) Poly (ADP-ribose) polymerase inhibits DNA replication by human replicative DNA polymerase alpha, delta and epsilon in vitro. FEBS Lett. 356:261–6.
36. Pagano A, Metrailler-Ruchonnet I, Aurrand- Lions M, Lucattelli M, Donati Y, Argiroffo CB. (2007) Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L619–29.
37. Rajesh M, et al. (2006) Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis. Biochem. Biophys. Res. Commun. 350:352–7.
38. Tentori L, et al. (2007) Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis. Eur. J. Cancer. 43:2124–33.
39. Pyriochou A, Olah G, Deitch EA, Szabo C, Papapetropoulos A. (2008) Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34. Int. J. Mol. Med. 22:113–8.
40. Mukhopadhyay P, et al. (2014) Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis. Hepatology. 59:1998–2009.
41. Bai P, et al. (2009) Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity. J. Invest. Dermatol. 129:234–8.